Funded by the EU


Assisted Reproductive Technologies and Haematopoietic stem cells Improvements for Quality and Safety throughout Europe is a 3 year European Joint Action funded by the European Commission under the 2008-13 Health Programme, dealing with Assisted Reproductive Technologies and Haematopoietic Stem Cells for Transplantations. This joint Action is coordinated by the Agence de la biomédecine in France. The management of ARTHIQS, technical (medical and scientific) work packages were simply divided in two sections corresponding with those 2 fields (see project organisation). The first section dedicated to ART (Assisted Reproductive Technologies) is leaded by the Agence de la biomédecine in France.

The other topic targeted by the ARTHIQS is Haematopoietic Stem Cells for Transplantation. This section is led by the Croatian Ministry of Health and co-led by the Italian ISS- Centro Nationale di Trapianti.

The main outcome of the ART should be the existence in all Member States, at the governmental level, of a sustainable structure: Competent Authority (or part of it)/ delegated body with a sufficient knowledge on Assisted Reproductive Technologies issues arose both by the European regulation (EUTCD, cross-border Directive) and by internal national regulation.

The outcome of the HSC part of the project are recommendations concerning the set-up of a Haematopoietic Stem Cells donor follow-up registry will set the basic framework for establishing registries as a tool for the upgrade/improvement of safety in Haematopoietic Stem Cells donation. The guidelines for Cord Blood Banks main outcome will be the establishment of EU common good practice in the field. Overall outcome will be a significant increase in quality and safety practices in cord blood banking, and Competent Authorities/ Delegated bodies having tools to assess the compliance of their Cord Blood Banks thanks to the guidelines generated. This last part of the work is also aiming at broader and safer Haematopoietic Stem Cells availabilities for patients in the need of a Haematopoietic Stem Cells transplant (providing that the use of cord blood is suitable), since it is the matter of transplanting the right patient at the right time with the right Haematopoietic Stem Cells source (bone marrow, Cord blood, peripheral Haematopoietic Stem Cells).

„It is clear that reaching ARTHIQS goals and designing such good practices is above all a team work and relies not only on multiple expertises but also on a strong synergy of ARTHIQS Consortium: Leaders & all Partners and collaborators. Everybody has a say and each contribution is important”.
Candide FONT-SALA,  ARTHIQS Coordinator, Agence de la biomédecine.

The sustainability of work will be ensured by one training meeting aimed to representatives of all Member States in both Assisted Reproductive Technologies and Haematopoietic Stem Cells, and by a careful dissemination strategy relying partly on the ARTHIQS partner in charge of communication, all ARTHIQS participants, professionals and scientific societies.

Candide FONT-SALA,  ARTHIQS Coordinator, Agence de la biomédecine

© 2014 ARTHIQS

ARTHIQS (Grant agreement n. 20132101557886) has received funding from the European Commission in the framework of the Health Programme. The sole responsibility lies with the author and the Consumers, Health and Food Executive Agency is not responsible of any use that may be made of the information contained here.